NewGenIvf Group shares rise 12.37% intraday after board approves 1-for-3 reverse stock split.

NewGenIVF Group surged 12.37% intraday trading after announcing a 1-for-3 reverse stock split scheduled for January 26th and appointing Joshua Chu, an award-winning Web3 leader, to its team. The reverse split, approved by the board on December 23, 2025, aims to consolidate shares without requiring shareholder approval, signaling a strategic move to streamline capital structure. The appointment of Chu, with expertise in Web3, further underscores the company’s pivot toward digital innovation, potentially attracting new investor interest. These developments align with the stock’s sharp intraday gain, reflecting positive market sentiment toward corporate restructuring and leadership changes.